15th Injectable Device Development Summit

The drug delivery landscape is evolving rapidly, with micro moulding driving evolving trends in self-injection devices and increasing drive towards sustainability. At the same time, sweeping regulatory shifts are reshaping the future of combination product development, as U.S. policy accelerates domestic drug approvals and heightens oversight of global manufacturing practices.

Built for device innovators by industry pioneers, the 15th Injectable Device Development Summit will unite 70+ senior leaders from pharma, biotech, and device service providers including Eli Lilly, Takeda, Sanofi, and Merck, to unpack how to enable flexible, patient-centric delivery platforms for high-viscosity, large-volume formulations. From advancing platform strategies to de-risking regulatory pathways and improving real-world usability, this is your essential forum to drive forward next-generation delivery systems that meet the needs of both regulators and patients.

To celebrate the 15th anniversary of this event, attendance will be FREE* for drug developers and researchers.

URLs:
Website: https://go.evvnt.com/3142389-0?pid=2874
Brochure: https://go.evvnt.com/3142389-3?pid=2874

Category: Exhibitions | Science, Health and Medicine | Medical and Pharmaceutical

Prices:
Conference Only (Drug Developers and Researchers): USD 0.00,
Conference Only (Service Providers): USD 3699.00

Speakers: Chanaka Amarasinghe, Bristol Myers Squibb, Rick Batish, Principal Engineer GSK, Alexandra Benbadis, Usability Engineering Lead Sanofi, Alison Bisch, AstraZeneca, Mayumi Bowen, Genentech, Richard Braga, Takeda, Sandipan Dawn, Ocular Therapeutix, Terence O’Hagan, Stevanato Group, Edward Hatton, Amneal Pharmaceuticals, Yik Kit (Grace) Kwok, Merck and Co., Steven Persak, Merck and Co., Lisa Ray, Eli Lilly, Kinkini Roy, Aviceda Therapeutics, Abhishek Telang, Senior Director, Device Quality and Regulatory Merck and Co.